What Are The Goals And Priorities Of The Average Scientist?

A 17-year-old high school student on the threshold of pursuing a scientific career worries about the public's perception of science and of what research brings to the world. A 72-year-old academic chemist is concerned that young scientists are looking to industry, rather than academia, for fulfilling work. These two people, at opposite ends of a professional lifetime, are different in many ways. But they, and three other researchers of different ages interviewed for this article, agree on many

Written byLisa Simon
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

These two people, at opposite ends of a professional lifetime, are different in many ways. But they, and three other researchers of different ages interviewed for this article, agree on many issues affecting their workaday lives. And although these scientists aren't among the scientific community's most eminent investigators, they share many of the same concerns.

In a survey of elite, well-known scientists conducted by The Scientist earlier this year (Jan. 7, 1991, page 1), there was a consensus that funding shortfalls for investigator-initiated projects, the need to encourage more young people to take up science careers, and the negative public perception of science are the most crucial problems confronting science in the 1990s. On the other hand, these key players pointed out that, in terms of scientific developments, this is a very exciting era, with new avenues in research opening up in the fields of neuroscience and molecular biology, among ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies